Nagoya, Japan

Kiichi Sawai


Average Co-Inventor Count = 6.4

ph-index = 9

Forward Citations = 259(Granted Patents)


Inventors with similar research interests:


Location History:

  • Funabashi, JP (1988 - 1995)
  • Aichi, JP (1989 - 1995)
  • Nagoya, JP (1989 - 1997)
  • Aichi-ken, JP (1998)

Company Filing History:


Years Active: 1988-1998

Loading Chart...
Areas of Expertise:
Antiviral Activity
Maillard Reaction Inhibitor
Motilin-Like Polypeptide
Hydantoin Derivatives
Nootropic Agents
Vasoactive Intestinal Polypeptide
Pharmaceutical Composition
Diabetes Treatment
Optically Active Compounds
Immunity Adjusting Compounds
Cloning of DNA
Edible Compositions
60 patents (USPTO):Explore Patents

Title: **Kiichi Sawai: Innovator in Antiviral Research**

Introduction

Kiichi Sawai, based in Nagoya, Japan, is a distinguished inventor with a remarkable portfolio of 60 patents. His contributions to scientific research and innovation have advanced the fields of antiviral activity and chemical reactions, marking him as a key figure in contemporary pharmaceutical and chemical research.

Latest Patents

Among his latest works, Sawai has developed several significant patents. One of the notable inventions is a **Potentiator for Interferon and an Antiviral Activity-Potentiating Composition**. This innovative potentiator combines flavin adenine dinucleotide (FAD) with porcine liver extract, showcasing a novel approach to enhance the effectiveness of interferon in antiviral treatments.

Another important patent is the **Maillard Reaction Inhibitor**, which features a distinctive eight-structural polymer of 3-oxygermylpropionic acid. This polymer is characterized by a specific stereostructure, where R represents -CH₂CH₂COOH. The innovation focuses on a weight average polymerization degree of approximately 137, with a standard deviation, providing a robust solution for inhibiting the Maillard reaction in various applications.

Career Highlights

Throughout his career, Kiichi Sawai has made significant strides in scientific research. He has worked with reputable organizations, including Sanwa Kagaku Kenkyusho Co., Ltd. and Kabushiki Kaisha Sanwa Kagaku Kenkyusho. These affiliations have allowed him to collaborate with leading professionals and contribute to numerous advancements in his field.

Collaborations

Sawai has partnered with notable colleagues, including Masayasu Kurono and Takahiko Mitani. These collaborations have not only enriched his research but also fostered innovation through the sharing of ideas and expertise, thus propelling advancements in biotechnology and chemistry.

Conclusion

Kiichi Sawai’s innovative spirit and commitment to research have yielded substantial patents and advancements in antiviral treatments and chemical reactions. His work has profoundly impacted the scientific community, reflecting a dedication to improving health outcomes. As his portfolio continues to grow, Sawai is poised to make further significant contributions to the fields of biotechnology and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…